Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration
Open Access
- 5 October 2016
- journal article
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 12932
Abstract
Prokineticin-2 (PK2), a recently discovered secreted protein, regulates important physiological functions including olfactory biogenesis and circadian rhythms in the CNS. Interestingly, although PK2 expression is low in the nigral system, its receptors are constitutively expressed on nigrostriatal neurons. Herein, we demonstrate that PK2 expression is highly induced in nigral dopaminergic neurons during early stages of degeneration in multiple models of Parkinson’s disease (PD), including PK2 reporter mice and MitoPark mice. Functional studies demonstrate that PK2 promotes mitochondrial biogenesis and activates ERK and Akt survival signalling pathways, thereby driving neuroprotection. Importantly, PK2 overexpression is protective whereas PK2 receptor antagonism exacerbates dopaminergic degeneration in experimental PD. Furthermore, PK2 expression increased in surviving nigral dopaminergic neurons from PD brains, indicating that PK2 upregulation is clinically relevant to human PD. Collectively, our results identify a paradigm for compensatory neuroprotective PK2 signalling in nigral dopaminergic neurons that could have important therapeutic implications for PD.Keywords
This publication has 58 references indexed in Scilit:
- Prokineticin 2 is an endangering mediator of cerebral ischemic injuryProceedings of the National Academy of Sciences, 2012
- Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's diseaseToxicology and Applied Pharmacology, 2011
- PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s DiseaseScience Translational Medicine, 2010
- A Small Molecule Inhibits Akt through Direct Binding to Akt and Preventing Akt Membrane TranslocationJournal of Biological Chemistry, 2010
- Inactivation of neuronal forebrain A2A receptors protects dopaminergic neurons in a mouse model of Parkinson’s diseaseJournal of Neurochemistry, 2009
- Inhibition of Prolyl Hydroxylase Protects against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced NeurotoxicityJournal of Biological Chemistry, 2009
- Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial FissionJournal of Biological Chemistry, 2009
- Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadismProceedings of the National Academy of Sciences, 2007
- Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neuronsProceedings of the National Academy of Sciences, 2007
- Expression of prokineticins and their receptors in the adult mouse brainJournal of Comparative Neurology, 2006